Honestly, if you’ve been watching the cannabis sector lately, it feels like a fever dream. One minute we're celebrating a massive policy shift, and the next, everyone is hitting the "sell" button like the building is on fire. It’s wild. If you’re looking for tlry stock news today, the big story isn't just a single headline—it's the massive disconnect between what the company is actually doing and how the market is reacting to it.
The stock took a breather recently, closing around $9.46 after some heavy volatility. Just a few days ago, it was flirting with double digits, driven by a cocktail of record-breaking revenue and some big moves from the White House. But then, as it usually goes with pot stocks, the "sell the news" crowd showed up.
The Record Revenue Nobody Is Talking About
Earlier this month, Tilray Brands (TLRY) dropped its fiscal second-quarter 2026 results. They actually beat expectations. Think about that for a second. In an industry where everyone is bleeding cash, Tilray pulled in a record $218 million in net revenue. That’s a 3% bump year-over-year.
It gets better. Their net loss narrowed significantly. Last year, they were losing $0.99 per share. This quarter? They cut that down to $0.41. It’s still a loss—let's be real, they aren't minting gold coins yet—but the trajectory is finally heading toward the black.
💡 You might also like: How Did Magic Johnson Make His Money? The Truth Behind the Billion-Dollar Pivot
The secret sauce here isn't even just weed. It’s the beer. And the hemp. And the distribution in Europe. Tilray has basically turned itself into a diversified consumer goods giant that just happens to sell a lot of cannabis. Their distribution business, Tilray Pharma, saw revenue jump 26% to $85.3 million.
That Executive Order Rollercoaster
We have to talk about the "Trump Bump." President Trump recently signed an executive order to move marijuana from Schedule I to Schedule III. On paper, this is huge. It basically acknowledges medical utility and, more importantly for the bean counters, it could eventually get rid of the 280E tax penalty that kills these companies.
But here’s where it gets messy.
The market initially went nuts, sending TLRY soaring. Then, the realization set in: an executive order isn't a magic wand. It doesn't mean you'll see Tilray-branded joints in every 7-Eleven by Tuesday. Because of that "incremental" feel, some investors got cold feet. We saw a 30% price drop over the last month as the hype cooled off.
It’s kinda funny, actually. The company is fundamentally stronger than it was a year ago, but the stock price is acting like they've hit a wall.
📖 Related: sgd dollar to philippine peso Explained: Why Your Remittance Is Suddenly More Expensive
Why the "Schedule III" News Matters More for Tilray Medical
Tilray didn't wait around for the paperwork to clear. They already launched Tilray Medical USA.
They are positioning themselves to dominate the "prescribed" side of the market. While everyone else is fighting over recreational dispensary licenses in saturated markets, Tilray is looking at the 3,000+ pharmacies they already have relationships with through their German operations. They want to clone that success in the States.
The Technical Reality
If you’re a chart person, tlry stock news today shows a bit of a tug-of-war.
The stock is currently trading below its 50-day moving average, which usually makes traders nervous. But, interestingly, it’s been holding above its 200-day moving average since December. In plain English? The short-term trend is "ouch," but the long-term trend is still showing some bullish momentum.
📖 Related: JBI Electrical Systems Inc: What Most People Get Wrong About Commercial Wiring
Analysts are all over the place. You've got some firms like Zacks recently moving to a "strong sell," while others like Atb Cap Markets upgraded them to a "hold." The consensus price target is still sitting around $15.00, which is a massive upside from where we are today.
Is Tilray a Buy or a Value Trap?
There are two ways to look at this.
- The Skeptic's View: The revenue growth is "sluggish" (only 3% year-over-year) compared to high-growth tech sectors. The company is still losing money, and they keep using "At-the-Market" programs to raise capital, which dilutes current shareholders.
- The Bull's View: They have a net cash position of $27.4 million. They aren't going bankrupt. They are the #1 cannabis player in Canada and the #4 craft brewer in the US. When the US market finally opens up for real, they have the infrastructure to move faster than anyone else.
Honestly, the risk-reward profile here is basically a bet on federal policy. If you think the Schedule III reclassification is just the first domino, $9.46 looks like a bargain. If you think Washington will keep dragging its feet for another decade, it’s a long, cold winter ahead.
What You Should Do Next
Keep a very close eye on the $9.30 support level. If the stock breaks below that on high volume, we could see a deeper slide toward the $8 range. However, if it holds, the "oversold" signals on the RSI (Relative Strength Index) might trigger a bounce.
Watch the "Dry January" numbers as well. Tilray has been pushing their non-alcoholic beers and hemp-derived THC beverages hard this month. If they show strong "alternative beverage" sales in the next update, it proves their diversification strategy is working, regardless of what the DEA decides to do with cannabis scheduling.
Monitor the institutional filings (13F). We've seen big players like Millennium Management increasing their stakes lately. When the big money starts quietly buying the dips, it usually means they see a bottom forming.
Actionable Insights for Investors:
- Check the 200-Day SMA: As long as TLRY stays above its 200-day moving average (currently around $10.70-ish but varying by day), the long-term recovery remains intact.
- Diversification is Key: Don't just track weed prices. Track Tilray’s craft beer performance. The "Beverage" segment is what provides the floor for this stock's valuation.
- Expect Volatility: This isn't a "set it and forget it" blue chip. Position sizing is everything. Never put more into a speculative play like TLRY than you are willing to see drop 20% in a week.